Interaction of vecuronium and atracurium during halothane anaesthesia in children

Anaesthesia

Volumn 53, Issue 1, 1998, Pages 36-40

  Sloan, Mark H ^a,b   Bissonnette, B ^a   Lerman, J ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b BAYSTATE MEDICAL CENTER   (United States)

Author keywords

Anaesthesia, paediatric; Anaesthetics, volatile, halothane; Neuromuscular relaxants, atracurium, vecuronium

Indexed keywords

ATRACURIUM; HALOTHANE; INHALATION ANESTHETIC AGENT; NEUROMUSCULAR BLOCKING AGENT; VECURONIUM;

ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; ELECTROMYOGRAPHY; HUMAN; INHALATION ANESTHESIA; MAJOR CLINICAL STUDY; MUSCLE EXCITATION; NEUROMUSCULAR BLOCKING; PEDIATRIC ANESTHESIA; RANDOMIZED CONTROLLED TRIAL; TIME;

ANESTHESIA, INHALATION; ANESTHETICS, INHALATION; ATRACURIUM; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ELECTROMYOGRAPHY; HALOTHANE; HUMANS; NEUROMUSCULAR JUNCTION; NEUROMUSCULAR NONDEPOLARIZING AGENTS; TIME FACTORS; VECURONIUM BROMIDE;

EID: 0031983316     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2044.1998.00259.x     Document Type: Article

References (16)

1. Waud BE, Waud DR. Interaction among agents that block end-plate depolarization competitively. Anesthesiology 1985; 63: 4-15.
2. Lebowitz PW, Ramsey FE, Savarese JJ, Ali HH, deBros FM. Combination of pancuronium and metocurine: neuromuscular and hemodynamic advantages over pancuronium alone. Anesthesia and Analgesia 1981; 60: 12-17.
3. Black TE, Healy TEJ, Pugh ND, et al. Neuromuscular block: atracurium and vecuronium compared and combined. European Journal of Anaesthesiology 1985; 2: 29-37.
4. Gibbs NM, Rung GW, Braunegg PW, Martins DE. The onset and duration of neuromuscular blockade using combinations of atracurium and vecuronium. Anaesthesia and Intensive Care 1991; 19: 96-100.
5. Van Der Spek AFL, Zupan JT, Pollard BJ, Schork MA. Interactions of vecuronium and atracurium in an in vitro nerve-muscle preparation. Anesthesia and Analgesia 1988; 67: 240-6.
6. Silverman DG, Swift CA, Hartman KA, Sinatra RS, Dubow HD. Onset of blockade with vecuronium alone or combined: a reassessment under uniform controlled conditions. Anesthesiology 1988; 69: 881.
7. Gregory GA, Eger EI, Munson ES. The relationship between age and halothane requirement in man. Anesthesiology 1969; 30: 488-91.
8. Taylor RH, Bissonnette B, Atkinson GR. Anaesthetic data logging using a PSION pocket computer (letter). Canadian Journal of Anaesthesia 1990; 37: 386-7.
9. Finney DJ. Probit Analysis, 2nd edn. Cambridge: The University Press, 1964.
10. Fisher DM, Fahey MR, Cronnelly R, Miller RD. Potency determination for vecuronium (ORG NC45): comparison of cumulative and single-dose techniques. Anesthesiology 1982; 57: 309-10.
11. Brandom BW, Rudd GD, Cook DR. Clinical pharmacology of atracurium in paediatric patients. British Journal of Anaesthesia 1983; 55: 117S-21S.
12. 2O, halothane anesthesia. Anesthesiology 1983; 58: 519-23.
13. Guralnik DB. Webster's New World Dictionary of the American Language, 2nd college edn. New York: The World Publishing Co., 1970.
14. Ginsberg B, Glass PS, Quill T, Shafron D, Ossey KD. Onset and duration of neuromuscular blockade following high-dose vecuronium administration. Anesthesiology 1989; 71: 201-5.
15. Tullock WC, Diana P, Cook DR, et al. Neuromuscular and cardiovascular effects of high-dose vecuronium. Anesthesia and Analgesia 1990; 70: 86-9.
16. Meretoja OA, Brandom BW, Taivainen T, Jalkanen L. Synergism between atracurium and vecuronium in children. British Journal of Anaesthesia 1993; 71: 440-2.